Q4 2021 ReShape Lifesciences Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the ReShape Lifesciences Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions)
Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to turn the conference over to your speaker for today, Michael Miller, Rx Communications. You may begin.
Good afternoon, and thank you for joining the Year-End 2021 ReShape Life Sciences Earnings Conference Call. I'm pleased to be joined by Bart Bandy, President and Chief Executive Officer of ReShape Lifesciences Inc, who will provide an overview of the company's activity during 2021 and milestones to date; Tom Stankovich, Chief Financial Officer of ReShape, will then review the financial results for the year, after which we will open up the call to a question-and-answer session.
As a reminder, this conference call, as well as ReShape Lifesciences' SEC
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |